JP2015213501A5 - - Google Patents

Download PDF

Info

Publication number
JP2015213501A5
JP2015213501A5 JP2015088066A JP2015088066A JP2015213501A5 JP 2015213501 A5 JP2015213501 A5 JP 2015213501A5 JP 2015088066 A JP2015088066 A JP 2015088066A JP 2015088066 A JP2015088066 A JP 2015088066A JP 2015213501 A5 JP2015213501 A5 JP 2015213501A5
Authority
JP
Japan
Prior art keywords
composition
composition according
individual
functional
acid bacterium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015088066A
Other languages
English (en)
Other versions
JP6035578B2 (ja
JP2015213501A (ja
Filing date
Publication date
Priority claimed from US14/259,442 external-priority patent/US10967013B2/en
Priority claimed from US14/690,502 external-priority patent/US10188684B2/en
Application filed filed Critical
Publication of JP2015213501A publication Critical patent/JP2015213501A/ja
Publication of JP2015213501A5 publication Critical patent/JP2015213501A5/ja
Application granted granted Critical
Publication of JP6035578B2 publication Critical patent/JP6035578B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (17)

  1. 登録番号DSM 28632でドイツ微生物細胞培養コレクション(DSMZ)に寄託しているラクトバチルス・プランタルム亜種プランタルム(Lactobacillus plantarum subsp. plantarum)PS128である単離乳酸菌。
  2. 請求項1に記載の単離乳酸菌と、担体とを含む組成物。
  3. 求項1に記載の単離乳酸菌を含む、個体のストレス誘発失調または精神障害を予防または治療するための組成物
  4. ストレス誘発失調または精神障害が不安、憂うつ及び過敏性腸症候群からなる群から選ばれる、請求項3に記載の組成物
  5. 清コルチコステロン濃度が個体において統計学的に有意に低下する、請求項3または4に記載の組成物
  6. 経伝達物質の濃度が個体において統計学的に有意に上昇する、請求項3または4に記載の組成物
  7. 神経伝達物質がドーパミンである請求項6に記載の組成物
  8. 求項1に記載の単離乳酸菌を含む、個体の機能性胃腸障害を予防または治療するための組成物
  9. 求項1に記載の単離乳酸菌を含む、個体の内臓過敏を予防または治療するための組成物
  10. 内臓過敏が機能性胃腸障害に関連する、請求項9に記載の組成物
  11. 機能性胃腸障害が機能性腹痛、過敏性腸症候群、便秘、機能性下痢と機能性消化不良からなる群から選ばれる、請求項8または10に記載の組成物
  12. 機能性胃腸障害が、機能性腹痛、過敏性腸症候群または便秘である、請求項11に記載の組成物
  13. 求項1に記載の単離乳酸菌を含む、個体の機能性腹痛、過敏性腸症候群または便秘を予防または治療するための組成物
  14. 覚のバイオマーカーレベルが個体において統計学的に有意に低下する、請求項8〜13のいずれか1項に記載の組成物
  15. バイオマーカーがP物質である、請求項14に記載の組成物
  16. 体の筋電図信号が統計学的に有意に低下する、請求項8〜13のいずれか1項に記載の組成物
  17. 口投与用である、請求項3〜16のいずれか1項に記載の組成物
JP2015088066A 2014-04-23 2015-04-23 乳酸菌、それを含む組成物及びそれらの使用 Active JP6035578B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US14/259,442 US10967013B2 (en) 2014-04-23 2014-04-23 Lactic acid bacterium for prophylaxis or treatment of a stress-induced disorder and a composition containing the same
US14/259,442 2014-04-23
US14/690,502 US10188684B2 (en) 2015-04-20 2015-04-20 Method for preventing or treating functional gastrointestinal disorder by lactic acid bacterium
US14/690,502 2015-04-20

Publications (3)

Publication Number Publication Date
JP2015213501A JP2015213501A (ja) 2015-12-03
JP2015213501A5 true JP2015213501A5 (ja) 2016-01-28
JP6035578B2 JP6035578B2 (ja) 2016-11-30

Family

ID=53008330

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015088066A Active JP6035578B2 (ja) 2014-04-23 2015-04-23 乳酸菌、それを含む組成物及びそれらの使用

Country Status (5)

Country Link
EP (1) EP2937424B1 (ja)
JP (1) JP6035578B2 (ja)
CN (1) CN105002109B (ja)
ES (1) ES2624673T3 (ja)
PL (1) PL2937424T3 (ja)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6933358B2 (ja) * 2016-04-06 2021-09-08 東海漬物株式会社 美肌促進剤
CN110023485B (zh) * 2016-07-19 2023-12-05 益福生医股份有限公司 利用乳酸菌预防或治疗运动障碍的方法
KR20180019474A (ko) * 2016-08-16 2018-02-26 주식회사 엠디헬스케어 락토바실러스 플란타룸 유래 소포를 포함하는 정신질환 예방 또는 치료용 조성물
CN107050062A (zh) * 2016-11-08 2017-08-18 江西益盟科技有限公司 治疗便秘的乳酸菌组合物及其制备方法
EP3568460A4 (en) * 2017-01-13 2020-09-23 Bened Biomedical Co., Ltd. NOVEL LACTIC ACID BACTERIA AND THEIR APPLICATIONS
KR102089836B1 (ko) * 2017-03-15 2020-03-16 (주)바이오일레븐 트립토판분해효소 음성균과 인터페론 감마 형성을 유도하는 균주를 이용한 염증성 질환 예방 및 치료용 약학적 조성물 또는 이를 이용한 치료방법
CN106906165B (zh) * 2017-04-25 2020-07-24 重庆第二师范学院 一种植物乳杆菌及其在制备预防便秘的食品中的应用
CN107267416A (zh) * 2017-07-05 2017-10-20 重庆第二师范学院 植物乳杆菌ys2及其在制备预防便秘的食品中的应用
WO2019119261A1 (en) * 2017-12-19 2019-06-27 Dupont Nutrition Biosciences Aps Probiotics for cognitive and mental health
KR20200112840A (ko) * 2017-12-19 2020-10-05 듀폰 뉴트리션 바이오사이언시즈 에이피에스 인지 및 정신 건강을 위한 프로바이오틱스
RU2764639C1 (ru) 2018-02-02 2022-01-19 Кобиолабс, Инк. Штамм kbl396 lactobacillus plantarum и его применение
CN111035661A (zh) * 2018-10-15 2020-04-21 深圳市华大农业应用研究院 植物乳杆菌的用途
TWI731279B (zh) 2018-11-21 2021-06-21 葡萄王生技股份有限公司 發酵乳桿菌gkf3、含其之組合物及改善精神失調之用途
ES2763350B2 (es) * 2018-11-28 2020-10-13 Consejo Superior Investigacion Cepa de christensenella minuta y uso de la misma
BR112021010794A2 (pt) * 2018-12-06 2021-08-31 Dupont Nutrition Biosciences Aps Probióticos para a saúde cognitiva e mental
WO2020156417A1 (en) * 2019-01-28 2020-08-06 Bened Biomedical Co., Ltd. Method for protecting a subject for exercise
CN113473998A (zh) * 2019-02-01 2021-10-01 农业食品和环境国家研究中心 用于预防和/或治疗内脏痛的乳酸乳球菌菌株
BR112021014935A2 (pt) * 2019-02-01 2021-09-28 Bened Biomedical Co., Ltd. Método para prevenir ou tratar uma emoção ou comportamento anormal em um animal não humano por meio de bactéria ácido-láctica
KR102148707B1 (ko) * 2019-02-22 2020-08-31 한국식품연구원 우울증 및 불안장애의 예방, 개선 또는 치료 효능을 갖는 김치 유산균 락토바실러스 사케아이
US20230035928A1 (en) * 2020-02-06 2023-02-02 Wang-Tso Lee Composition of lactic acid bacterium for use in preventing or treating rett syndrome
WO2022083754A1 (en) * 2020-10-22 2022-04-28 Lee Wang Tso Lactic acid bacterium for treatment of aromatic l-amino acid decarboxylase deficiency
WO2022131192A1 (ja) * 2020-12-16 2022-06-23 株式会社明治 脳組織の炎症改善用組成物
CN113215018A (zh) * 2021-02-04 2021-08-06 郑州大学 一株植物乳杆菌植物亚种及其在豆粕和北艾混合发酵中的应用
CN113564084A (zh) * 2021-08-13 2021-10-29 华东理工大学 植物乳杆菌x7022在预防和治疗便秘上的应用
TWI810645B (zh) * 2021-09-06 2023-08-01 景岳生物科技股份有限公司 乳桿菌組合物及其改善抗生素造成之焦慮症的用途
WO2024089260A1 (en) * 2022-10-28 2024-05-02 Chr. Hansen A/S Lactiplantibacillus plantarum for use in addressing the symptoms of irritable bowel syndrome

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5725853A (en) * 1994-10-18 1998-03-10 Pioneer Hi-Bred International, Inc. 4 strain direct-fed microbial
US20050158294A1 (en) * 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
EP2332539A4 (en) * 2008-08-21 2012-05-09 Suntory Holdings Ltd PHARMACEUTICAL PREPARATION, FOOD OR BEVERAGE WITH ANTICIPATIVE EFFECT ON THE SEROTONINE TRANSPORTER

Similar Documents

Publication Publication Date Title
JP2015213501A5 (ja)
Jiang et al. Evaluation of probiotic properties of Lactobacillus plantarum WLPL04 isolated from human breast milk
Wang et al. Swine-derived probiotic Lactobacillus plantarum inhibits growth and adhesion of enterotoxigenic Escherichia coli and mediates host defense
Sokovic Bajic et al. GABA-producing natural dairy isolate from artisanal zlatar cheese attenuates gut inflammation and strengthens gut epithelial barrier in vitro
EP4272815A3 (en) New medical use of probiotics
Hojjati et al. Aggregation, adherence, anti-adhesion and antagonistic activity properties relating to surface charge of probiotic Lactobacillus brevis gp104 against Staphylococcus aureus
Presti et al. Evaluation of the probiotic properties of new Lactobacillus and Bifidobacterium strains and their in vitro effect
Nueno-Palop et al. Probiotic assessment of Enterococcus faecalis CP58 isolated from human gut
Álvarez-Cisneros et al. Antibiotic resistance in lactic acid bacteria
Brisbin et al. Effects of lactobacilli on cytokine expression by chicken spleen and cecal tonsil cells
Matsuzaki et al. Immunomodulating activity of exopolysaccharide‐producing Leuconostoc mesenteroides strain NTM048 from green peas
CN108779431B (zh) 功能性水合透明质酸及其制备具优良肠粘膜粘附能力和选择性拮抗作用的包衣乳酸菌的方法
Zhang et al. Antagonistics against pathogenic Bacillus cereus in milk fermentation by Lactobacillus plantarum ZDY2013 and its anti-adhesion effect on Caco-2 cells against pathogens
Helmy et al. In vitro evaluation of the impact of the probiotic E. coli Nissle 1917 on Campylobacter jejuni’s invasion and intracellular survival in human colonic cells
RU2010142003A (ru) Синбиотическая смесь
RU2016143921A (ru) Композиция для применения в лечении или предупреждении вирусных или бактериальных инфекций у субъекта, проходящего противоопухолевую химиотерапию, лечение лейкоза или лечение СПИД, содержащая l.reuteri ler03 и/или l.salivarius ls06
Kook et al. Isolation and characterization of five novel probiotic strains from Korean infant and children faeces
Nawaz et al. Screening and characterization of new potentially probiotic lactobacilli from breast-fed healthy babies in Pakistan
Han et al. Antibiotic susceptibility of potentially probiotic Lactobacillus strains
Dhanani et al. Lactobacillus plantarum CS24. 2 prevents Escherichia coli adhesion to HT‐29 cells and also down‐regulates enteropathogen‐induced tumor necrosis factor‐α and interleukin‐8 expression
Mandal et al. Isolation and characterization of lactobacilli from human faeces and indigenous fermented foods for their potential application as probiotics
Saroj et al. Lactobacilli interfere with Streptococcus pyogenes hemolytic activity and adherence to host epithelial cells
Luo et al. Identification and characterization of lactic acid bacteria from forest musk deer feces
Hossain et al. Characterization of virulence determinants and multiple antimicrobial resistance profiles in motile Aeromonas spp. isolated from ornamental goldfish (Carassius auratus)
Tanriover et al. Use of probiotics in various diseases: Evidence and promises